EFEarnings Feed

Filing detail

6-KTicker CMNDCIK 0001892500

Clearmind Medicine Inc. 6-K

Accession 0001213900-25-109965

Filed Nov 12, 7:00 PM ETAccepted Nov 13, 4:01 PM ETSize 25.0 KB
View on sec.gov ↗Open company profile

Filed (ET)

Nov 12, 7:00 PM ET

Accepted

Nov 13, 4:01 PM ET

File size

25.0 KB

SEC accession

0001213900-25-109965

Filing details

Company
Clearmind Medicine Inc.
CIK
0001892500
Incorporated
Canada (Federal Level)
Entity type
other

Related parties

  • filerCIK 0001892500

Documents

Attached files
3 items

  • ea0265514-6k_clearmind.htm

    6-K

    REPORT OF FOREIGN PRIVATE ISSUER

    PrimaryOpen file ↗

  • ea026551401ex99-1_clearmind.htm

    EX-99.1

    PRESS RELEASE TITLED: "CLEARMIND MEDICINE RECEIVES FINAL APPROVAL TO EXPAND ITS FDA REGULATED PHASE 1/2A CLINICAL TRIAL FOR ALCOHOL USE DISORDER AT HADASSAH MEDICAL CENTER"

    Open file ↗

  • ex99-1_001.jpg

    GRAPHIC

    GRAPHIC

    Open file ↗